[Pharmaceutical patents and the accessibility of drugs in Brazil].
Passage of Patent Law 9279/96, in effect since April 1997, has made relations between pharmaceutical patents and accessibility to medicine in Brazil complex. Under the new law, patents may extend to chemical inventions (products and process) and transgenic microorganisms. The issue is analyzed from two specific yet inter-related approaches: science and technology policy and health-care policy. The conclusion draws attention to the main future consequences of current international trends, both legal and regulatory. Brazil should ready its legal framework to respond to the negative consequences that genome patenting can be expected to have on the flow of scientific information and on access to pharmaceutical drugs.
Marques
M B
MB
Centro de Informacao Cientifica e Technologica de Fundacao Oswaldo Cruz, Brasil.
D001938:Brazil; D049673:History, 20th Century; D007880:Legislation, Drug / Q000266:history*; D010330:Patents as Topic / Q000266:history*
Patentes farmaceuticas e acessibilidade aos medicamentos no Brasil.